Newsroom
Three Selvedge Venture portfolio companies were featured in the April issue of Nature
Nature has published their April 2022 Biopharma Dealmakers collection on the Advances in Artificial Intelligence-Driven Drug Development presenting companies "h ...
On a journey to drastically speed up cell therapy manufacturing, Kytopen lands $30M Series A
Spun out of an MIT lab, sitting in an office space above a Cambridge tapas restaurant from world-renowned chef Ken Oringer is a biotech focused on drastically r ...
London-based health startup snaps up £2M to turbocharge diagnostics development with clinically validated home testing
The complexity of health and disease cannot be captured by a singular diagnostic test and therefore can’t be expected to deliver true impact. Attempting to crea ...
WSJ features Ochre Bio: “Biotech Startup Ochre Bio Lands Seed Financing to Combat Liver Diseases”
Brian Gormley of The Wall Street Journal has featured Ochre Bio and their novel approach to tackling chronic liver disease (a top ten cause of death globally). ...
CogX Shortlists BIOS in their AI awards for Best Innovation in Pharma
We are thrilled to announce that BIOS was shortlisted for the "Best Innovation in Pharma" in this year's CogX Awards.The CogX Awards are the most exciting celeb ...
These Are The Top 101 Therapeutics Startups to Follow in 2021
This article showcases Startup Pill’s top picks for the best Therapeutics startups. These startups are taking a variety of approaches to innovating inside of th ...
Lyfebulb-CSL Behring Innovation Challenge: Thriving with Transplantation
The goal of the 2021 Lyfebulb-CSL Behring Innovation Challenge: Thriving with Transplantation is to source innovative solutions to improve outcomes and experien ...
BIOS wins the WIRED Health EY Startup Showcase
We’re delighted to announce the winner of the WIRED Health EY Startup Showcase is Oliver Armitage, the co-founder of BIOS Health Ltd. “BIOS is transla ...